Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kirch

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Virology|April 20, 1999
Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cellsH Rumpf, H Esche, H C Kirch
The International Journal of Biochemistry|January 1, 1987
Binding of chondroitin sulfate, dermatan sulfate and fat-storing cell-derived proteoglycans to rat hepatocytesH C Kirch, M Lammers, A M Gressner
Nucleic Acids Research|June 11, 1991
A new fast and easy method for the oligonucleotide affinity purification of DNA binding proteinsH C Kirch, H Krüger, H S Holthausen
Oncogene|April 18, 1996
Repression of c-Jun-induced mouse major histocompatibility class I promoter (H-2Kb) activity by the Adenovirus type 12-unique 52R E1A proteinD Brockmann, D Schäfer, H C Kirch, et al.
British Journal of Haematology|January 14, 1999
Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemiaJ K Schröder, C Kirch, S Seeber, et al.
Annals of the New York Academy of Sciences|June 8, 2000
Very low density lipoprotein overproduction is maximally expressed in early insulin resistant statesJ Pietzsch, U Julius, C Kirch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Recurrent ifosfamide-induced hyponatraemiaC Kirch, B Gachot, N Germann, et al.
European Journal of Clinical Investigation|April 12, 2000
Effect of digoxin on circadian blood pressure values in patients with congestive heart failureC Kirch, M Grossmann, S Fischer, et al.
Oncogene|May 29, 1999
Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/MaxH C Kirch, S Flaswinkel, H Rumpf, et al.
The Journal of Biological Chemistry|May 5, 1995
Repression of the c-Jun trans-activation function by the adenovirus type 12 E1A 52R protein correlates with the inhibition of phosphorylation of the c-Jun activation domainD Brockmann, C Bury, G Kröner, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Virology|April 20, 1999
Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cellsH Rumpf, H Esche, H C Kirch
The International Journal of Biochemistry|January 1, 1987
Binding of chondroitin sulfate, dermatan sulfate and fat-storing cell-derived proteoglycans to rat hepatocytesH C Kirch, M Lammers, A M Gressner
Nucleic Acids Research|June 11, 1991
A new fast and easy method for the oligonucleotide affinity purification of DNA binding proteinsH C Kirch, H Krüger, H S Holthausen
Oncogene|April 18, 1996
Repression of c-Jun-induced mouse major histocompatibility class I promoter (H-2Kb) activity by the Adenovirus type 12-unique 52R E1A proteinD Brockmann, D Schäfer, H C Kirch, et al.
British Journal of Haematology|January 14, 1999
Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemiaJ K Schröder, C Kirch, S Seeber, et al.
Annals of the New York Academy of Sciences|June 8, 2000
Very low density lipoprotein overproduction is maximally expressed in early insulin resistant statesJ Pietzsch, U Julius, C Kirch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Recurrent ifosfamide-induced hyponatraemiaC Kirch, B Gachot, N Germann, et al.
European Journal of Clinical Investigation|April 12, 2000
Effect of digoxin on circadian blood pressure values in patients with congestive heart failureC Kirch, M Grossmann, S Fischer, et al.
Oncogene|May 29, 1999
Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/MaxH C Kirch, S Flaswinkel, H Rumpf, et al.
The Journal of Biological Chemistry|May 5, 1995
Repression of the c-Jun trans-activation function by the adenovirus type 12 E1A 52R protein correlates with the inhibition of phosphorylation of the c-Jun activation domainD Brockmann, C Bury, G Kröner, et al.
Pageof 3